EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Giant Cell Myocarditis with Prolonged Cardiac Standstill After Drug-Induced Hypersensitivity Syndrome: A Case Report

Ryohei Ono iD, Hiroki Kohno, Sae Kaminota, Kaoruko Aoki, Hirotoshi Kato, Togo Iwahana, Takanori Aihara, Masayuki Ota, Goro Matsumiya, Yoshio Kobayashi

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14678 ↗

Kurz gefasst

Fallbericht in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Ryohei Ono und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. Hauptthemen laut MEDLINE: Myocarditis, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Giant cell myocarditis (GCM) is a rare but fatal disease that can lead to cardiac failure. Survival with a cardiac standstill requires mechanical circulatory support or a biventricular assist device (BiVAD) and prolonged survival is extremely rare. Drug-induced hypersensitivity syndrome (DIHS) is a severe cutaneous adverse reaction. Some cases of DIHS are reportedly associated with the onset of GCM. We present a case of a 28-year-old woman who developed GCM during steroid tapering after DIHS. She went into continuous cardiac standstill but survived for 74 days under BiVAD support. Our case is noteworthy because the histopathologic specimens obtained on three occasions contributed to the diagnosis of this particular condition over time. We also reviewed previous literature on concomitant cases of GCM and DIHS. We found that two are potentially associated and most cases of GCM occur within 3 months of DIHS during steroid tapering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisHeart FailureFemaleHumansAdultGiant CellsSteroids

Stichwörter der Autor:innen

Biventricular assist deviceCardiac arrestCardiac standstillDrug‐induced hypersensitivity syndromeGiant cell myocarditisReview

Substanzen

Steroids

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Chiba University School of Medicine, Chiba, Japan.
  • Department of Pathology, Chiba University Hospital, Chiba, Japan.
  • Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan.

ORCID-Profile: Ryohei Ono

Förderung

  • JSPS KAKENHI

Zitieren

APA

Ono, R., Kohno, H., Kaminota, S., Aoki, K., Kato, H., Iwahana, T., Aihara, T., Ota, M., Matsumiya, G., & Kobayashi, Y. (2024). Giant Cell Myocarditis with Prolonged Cardiac Standstill After Drug-Induced Hypersensitivity Syndrome: A Case Report. ESC Heart Failure. https://doi.org/10.1002/ehf2.14678

Vancouver

Ono R, Kohno H, Kaminota S, Aoki K, Kato H, Iwahana T, et al. Giant Cell Myocarditis with Prolonged Cardiac Standstill After Drug-Induced Hypersensitivity Syndrome: A Case Report. ESC Heart Failure. 2024. doi:10.1002/ehf2.14678

BibTeX
@article{Ono2024,
  author = {Ono, Ryohei and Kohno, Hiroki and Kaminota, Sae and Aoki, Kaoruko and Kato, Hirotoshi and Iwahana, Togo and Aihara, Takanori and Ota, Masayuki and Matsumiya, Goro and Kobayashi, Yoshio},
  title = {Giant Cell Myocarditis with Prolonged Cardiac Standstill After Drug-Induced Hypersensitivity Syndrome: A Case Report},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14678}
}
Kostenlos starten →